Astrazeneca Covid-19 Vaccines To India
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
- Tuesday December 21, 2021
- Science | Press Trust of India
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
- www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
- www.ndtv.com
-
Booster Dose Of 6 Covid Vaccines Safe, Increases Immunity: Lancet Study
- Friday December 3, 2021
- India News | Press Trust of India
Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal.
- www.ndtv.com
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
- Thursday December 2, 2021
- World News | Press Trust of India
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
- Monday October 18, 2021
- World News | Press Trust of India
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
- www.ndtv.com
-
Pfizer, AstraZeneca Vaccine Antibody Levels May Decline In 2-3 Months: Lancet Study
- Tuesday July 27, 2021
- Science | Press Trust of India
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.
- www.ndtv.com
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
- Wednesday June 23, 2021
- India News | Reuters
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
- www.ndtv.com
-
Vaccines From Pfizer, AstraZeneca Protect Against Delta Strain: Study
- Monday June 14, 2021
- World News | Katharine Gemmell, Bloomberg
People infected with COVID-19's delta variant, first detected in India, are more than twice as likely to end up in the hospital than with the alpha variant identified in the U.K. last year.
- www.ndtv.com
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
- Thursday June 10, 2021
- Science | Press Trust of India
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
- www.ndtv.com
-
How to Download COVID-19 Vaccine Certificate
- Friday May 14, 2021
- Tasneem Akolawala
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
- www.gadgets360.com
-
Bangladesh Gets 5 Lakh Chinese COVID-19 Vaccine Doses As Gift
- Wednesday May 12, 2021
- World News | Press Trust of India
Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.
- www.ndtv.com
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
- Thursday May 16, 2024
- World News | Indo-Asian News Service
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
- Tuesday December 21, 2021
- Science | Press Trust of India
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
- www.ndtv.com
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
- Monday December 6, 2021
- World News | Press Trust of India
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
- www.ndtv.com
-
Booster Dose Of 6 Covid Vaccines Safe, Increases Immunity: Lancet Study
- Friday December 3, 2021
- India News | Press Trust of India
Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal.
- www.ndtv.com
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
- Thursday December 2, 2021
- World News | Press Trust of India
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
- Monday October 18, 2021
- World News | Press Trust of India
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
- www.ndtv.com
-
Pfizer, AstraZeneca Vaccine Antibody Levels May Decline In 2-3 Months: Lancet Study
- Tuesday July 27, 2021
- Science | Press Trust of India
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.
- www.ndtv.com
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
- Wednesday June 23, 2021
- India News | Reuters
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
- www.ndtv.com
-
Vaccines From Pfizer, AstraZeneca Protect Against Delta Strain: Study
- Monday June 14, 2021
- World News | Katharine Gemmell, Bloomberg
People infected with COVID-19's delta variant, first detected in India, are more than twice as likely to end up in the hospital than with the alpha variant identified in the U.K. last year.
- www.ndtv.com
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
- Thursday June 10, 2021
- Science | Press Trust of India
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
- www.ndtv.com
-
How to Download COVID-19 Vaccine Certificate
- Friday May 14, 2021
- Tasneem Akolawala
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
- www.gadgets360.com
-
Bangladesh Gets 5 Lakh Chinese COVID-19 Vaccine Doses As Gift
- Wednesday May 12, 2021
- World News | Press Trust of India
Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.
- www.ndtv.com